Sanofi and Translate Bio join forces on mRNA vaccine
The deal between the French and US drugmakers, working on a new type of vaccine for the coronavirus, could be worth up to $2.3bn
23 June 2020 - 11:45
Geneva — French drugmaker Sanofi is strengthening its pact with US vaccine developer Translate Bio to develop shots for Covid-19 and the flu in a deal that could be valued at as much as $2.3bn.
Sanofi will pay $425m upfront, the companies said on Tuesday. The French company also agreed to pay as much as $1.9bn on meeting various goals, plus royalties...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.